Microsure receives CE mark approval for MUSA-3 microsurgery robot
Evidence notes
- Microsure received CE mark approval for MUSA-3, enabling clinical use of the microsurgical robot in Europe.
- The approval moves MUSA-3 from product development into a clinical medical-device phase focused on evidence generation and adoption.
- Microsure said the next phase will focus on clinical evidence at leading European centres and partnerships for supermicrosurgical procedures.
Company context
Microsure is a Dutch medical robotics company developing robot-assisted systems for open microsurgery and supermicrosurgery. Its MUSA platform is designed to let surgeons perform high-precision procedures using scaled, tremor-filtered joystick control while retaining their own microsurgical instruments through disposable adapters.